Avid Bioservices Inc (CDMO)

[biopharm]

Interesting how the FDA has not publicly responded how inferior the FDA system has been working ...

Maybe Laura Benjamin will just say it's not her job but then again they all blame someone else. Imagine that...paid pawns when they take an oath to bring the best medicines forward unless they listen to certain Big Pharmas that tell then they must attack the individual receptors and fail fiduciary duties of the shareholder

Did Peregrine or Avid ever post ALL details of the complete IP assets transfers? I don't think so

..PPHM will have to be very careful given we have at least 3 (and possible 4 given PACER mentioned viral clinical trials at CSM too) of our clinical trial with events that were CLEARLY in the disadvantage of PPHM and ALL in a DIFFERENT WAYS!

- 1st ln NSCLC control arm set's new SOC on itself equal to the SUPER Bavituximab results.

- Pancreatic trial sees the large and disproportional sickest patients population randomized in the Bavituximab arm (and the Bavi arm STILL has beaten the SOC but only with two weeks).

- 2nd ln NSCLC that was sabotaged with a dose switching on a registration al trial that could have set Bavituximab in commercial production rather then having to run SUNRISE. A sabotage that was EXTREMELY unfavourable for the Bavituximab arms, yet still yielded super 60% SOC improvement (conservative) and 113% SOC improvement and statistical significant in reality. And one that crossed CEO King's statement that we expected to have a commercial product in 2012.

So the next thing, if any, will be something more sophisticated and what better way then to hide it in an at first view POSITIVE event such as an EARLY STOP advice of a look-in. There is not much needed to have a hand into a IDMC. I am not saying this is going to happen, just that it could, and that PPHM needs to make sure that every move they make is on SOLID GROUND.
.....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137852390